These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials? Tang SC Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770 [TBL] [Abstract][Full Text] [Related]
9. [Monitoring the safety of participants in randomised clinical trials: basis and methods]. Tijssen JG Ned Tijdschr Geneeskd; 2008 Mar; 152(12):674-8. PubMed ID: 18438062 [TBL] [Abstract][Full Text] [Related]
10. Current controversies in data monitoring for clinical trials. Pocock SJ Clin Trials; 2006; 3(6):513-21. PubMed ID: 17170035 [TBL] [Abstract][Full Text] [Related]
11. Planning for closeout--from Day One. Shepherd R; Macer JL; Grady D Contemp Clin Trials; 2008 Mar; 29(2):136-9. PubMed ID: 17644047 [TBL] [Abstract][Full Text] [Related]
12. [Clinical researchers and the pharmaceutical industry. Usefulness and need for an independent steering committee]. Van Gijn J; Algra A Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1477-9. PubMed ID: 10443264 [TBL] [Abstract][Full Text] [Related]
13. Refining the postmenopausal breast cancer treatment paradigm: the FACE trial. Monnier A Expert Rev Anticancer Ther; 2006 Oct; 6(10):1355-9. PubMed ID: 17069521 [TBL] [Abstract][Full Text] [Related]
14. How to anticipate the assessment of the public health benefit of new medicines? Massol J; Puech A; Boissel JP; Therapie; 2007; 62(5):427-35. PubMed ID: 18206104 [TBL] [Abstract][Full Text] [Related]
15. One-sided sequential stopping boundaries for clinical trials: a decision-theoretic approach. Berry DA; Ho CH Biometrics; 1988 Mar; 44(1):219-27. PubMed ID: 3358990 [TBL] [Abstract][Full Text] [Related]
16. Issues in the use of adaptive clinical trial designs. Emerson SS Stat Med; 2006 Oct; 25(19):3270-96; discussion 3302-4, 3320-5, 3326-47. PubMed ID: 16906553 [TBL] [Abstract][Full Text] [Related]
17. Operating characteristics of sample size re-estimation with futility stopping based on conditional power. Lachin JM Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019 [TBL] [Abstract][Full Text] [Related]